Terms: = Leukemia AND CARS, P49589, 833, ENSG00000110619 AND Clinical Outcome
4 results:
1. Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies.
Araie H; Kawaguchi Y; Okabe M; Lee Y; Ohbiki M; Osaki M; Goto M; Goto T; Morishita T; Ozawa Y; Miyamura K
Int J Hematol; 2019 Nov; 110(5):599-605. PubMed ID: 31407255
[TBL] [Abstract] [Full Text] [Related]
2. Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive leukemia and Lymphoma in the Context of Stem Cell Transplantation.
Schubert ML; Hückelhoven A; Hoffmann JM; Schmitt A; Wuchter P; Sellner L; Hofmann S; Ho AD; Dreger P; Schmitt M
Hum Gene Ther; 2016 Oct; 27(10):758-771. PubMed ID: 27479233
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials.
Xu XJ; Zhao HZ; Tang YM
Leuk Lymphoma; 2013 Feb; 54(2):255-60. PubMed ID: 22897728
[TBL] [Abstract] [Full Text] [Related]
4. [Current and new therapeutic strategies in acute myeloid leukemia].
Naito K; Ohnishi K
Gan To Kagaku Ryoho; 2005 Mar; 32(3):292-6. PubMed ID: 15791811
[TBL] [Abstract] [Full Text] [Related]
